ClinicalTrialsFinder

Sickle Cell Anemia Clinical Trials in Al Mathar Ash Shamali

1 recruitingAl Mathar Ash Shamali, Saudi Arabia

Showing 1–1 of 1 trials

Recruiting
Phase 3

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

Beta-ThalassemiaSickle Cell DiseaseHematologic Diseases+4 more
Vertex Pharmaceuticals Incorporated26 enrolled6 locationsNCT05477563